Furthermore, the RT‐qPCR results also showed significantly decreased mRNA expression of c‐Myc and Bcl‐2 and increased levels of Bax and caspase‐3 in BBI608‐treated ovarian cancer cells (Figure 4F,G, P < .05). This evidence concerns the gene BCL2 and ovarian cancer.